0001123292-17-001368.txt : 20170821
0001123292-17-001368.hdr.sgml : 20170821
20170821175644
ACCESSION NUMBER: 0001123292-17-001368
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170821
FILED AS OF DATE: 20170821
DATE AS OF CHANGE: 20170821
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mattila Jyrki
CENTRAL INDEX KEY: 0001297318
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 171043830
MAIL ADDRESS:
STREET 1: AUXILIUM PHARMACEUTICALS, INC.
STREET 2: 40 VALLEY STREAM PARKWAY
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (484) 395-2400
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-08-21
0001588972
Recro Pharma, Inc.
REPH
0001297318
Mattila Jyrki
C/O RECRO PHARMA, INC.
490 LAPP ROAD
MALVERN
PA
19355
0
1
0
0
Executive VP, Business Dev.
Employee Stock Option (right to buy)
6.98
2017-08-21
4
A
0
75000
0
A
2027-08-21
Common Stock
75000
75000
D
Restricted Stock Units
2017-08-21
4
A
0
12000
0
A
Common Stock
12000
12000
D
The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company. The stock option is an inducement grant under NASDAQ listing rule 5635(c)(4).
Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
The restricted stock units vest in four equal annual installments beginning August 21, 2018. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. The restricted stock unit award is an inducement grant under NASDAQ listing rule 5635(c)(4).
/s/ Ryan D. Lake, attorney-in-fact
2017-08-21